GURUFOCUS.COM » STOCK LIST » Industrials » Business Services » Proto Script Pharmaceutical Corp (OTCPK:PSCR) » Definitions » Forward Dividend Yield %

Proto Script Pharmaceutical (Proto Script Pharmaceutical) Forward Dividend Yield % : 0.00% (As of May. 24, 2024)


View and export this data going back to 2011. Start your Free Trial

What is Proto Script Pharmaceutical Forward Dividend Yield %?

As of today (2024-05-24), the Forward Annual Dividend Yield of Proto Script Pharmaceutical is 0.00%.

As of today (2024-05-24), the Trailing Annual Dividend Yield of Proto Script Pharmaceutical is 0.00%.

PSCR's Forward Dividend Yield % is not ranked *
in the Business Services industry.
Industry Median: 3.205
* Ranked among companies with meaningful Forward Dividend Yield % only.

Proto Script Pharmaceutical's Dividends per Share for the three months ended in Sep. 2017 was $0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.


Competitive Comparison of Proto Script Pharmaceutical's Forward Dividend Yield %

For the Specialty Business Services subindustry, Proto Script Pharmaceutical's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Proto Script Pharmaceutical's Forward Dividend Yield % Distribution in the Business Services Industry

For the Business Services industry and Industrials sector, Proto Script Pharmaceutical's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Proto Script Pharmaceutical's Forward Dividend Yield % falls into.



Proto Script Pharmaceutical Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.


Proto Script Pharmaceutical  (OTCPK:PSCR) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


Proto Script Pharmaceutical Forward Dividend Yield % Related Terms

Thank you for viewing the detailed overview of Proto Script Pharmaceutical's Forward Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Proto Script Pharmaceutical (Proto Script Pharmaceutical) Business Description

Traded in Other Exchanges
N/A
Address
9830 6th Street, Suite 103, Rancho Cucamonga, CA, USA, 91730
Proto Script Pharmaceutical Corp is primarily in the business of repair power wheelchairs and scooters, which are classified as durable medical equipment (DME) products and reimbursable by healthcare insurance providers. It has various contracts with state and governmental insurance providers, among others. These contracts provide the company with the right to sell and repair DME and its health care insurance contracts allow it the ability to service patients nationally. The group currently has its presence of repair facilities in Las Vegas, Nevada, Rancho-Cucamonga, and Anaheim, California.

Proto Script Pharmaceutical (Proto Script Pharmaceutical) Headlines

No Headlines